[Event Report] APEC Workshop “Incentives to Bring New Antibiotics to APEC Markets” (July 31, August 1, 2023, Seattle, USA)
date : 8/29/2023
Tags: AMR
![[Event Report] APEC Workshop “Incentives to Bring New Antibiotics to APEC Markets” (July 31, August 1, 2023, Seattle, USA)](https://hgpi.org/en/wp-content/uploads/sites/2/lecture-media-234-top.jpg)
On July 31 and August 1, Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno presented at the APEC Workshop “Incentives to Bring New Antibiotics to APEC Markets” held in Seattle, USA.
The Asia-Pacific Economic Cooperation (APEC) is a framework for economic cooperation among 21 countries and regions (called “economies”) in the Asia-Pacific region. The United States will chair APEC in 2023, and various discussions among economies are underway under the theme of “Creating a Resilient and Sustainable Future for All”. This workshop was held on the sidelines of the 3rd APEC Senior Officials Meeting (SOM).
Ms. Kohno’s presentation titled “2024 and Beyond” touched on the importance of international and multi-stakeholder collaboration, the importance of patients and patient engagement, and expectations for the United Nations High-Level Meeting in 2024.
Additionally, she shared HGPI’s perspective on the progress and trends in Japan’s AMR-related policies, including from the G7 Hiroshima Summit, National Action Plan on Antimicrobial Resistance and various incentive mechanisms.
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care” (January 31, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Discussion Points] Intractable & Rare Diseases Project Discussion Paper “Intractable & Rare Diseases 2025: 10 Years After the Passing of the Intractable Diseases Act, Toward a Co-created Future” (Mar 28, 2025)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] HGPI Endorsed “Civil Society’s Expectations for the Continuation and Development of Japan’s Global Health Initiatives” (March 17, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
Featured Posts
-
2025-03-26
[Registration Open] (Webinar) The 132nd HGPI Seminar “Considering the Ideal Evidence-Based Immunization and Vaccination Policies” (April 25, 2025)
-
2025-04-02
[Registration Open] Public Event “The Patient and Citizen Lived Experience Forum 2025” (May 17, 2025)
-
2025-04-17
[Registration Open] (Webinar) The 134th HGPI Seminar “Understanding Evidence-Based Dietary Guidelines: Leveraging the Dietary Reference Intakes for Japanese” (May 28, 2025)
-
2025-04-23
[Registration Open] Recruitment of the Health Policy Academy the 14th Session (Starts July 2025)
-
2025-04-23
[HGPI Policy Column] (No.58) — From the Global Health Strategy Project — “Toward Fair Health Systems: The Power of Data in Advancing UHC and Supporting Health Financing”